Catch up on the top radiology content of the past week.
|Articles|December 28, 1994
Visiplex buys Nuclear Data camera
Multiformat camera and PACS firmVisiplex Instruments last month acquired worldwide sales and marketingrights to Nuclear Data's IV 4600 film recorder, which recordsvideo images from modalities that use an ultra-high line videosignal. The acquisition is
Advertisement
Multiformat camera and PACS firmVisiplex Instruments last month acquired worldwide sales and marketingrights to Nuclear Data's IV 4600 film recorder, which recordsvideo images from modalities that use an ultra-high line videosignal. The acquisition is the first step in a Visiplex plan toacquire Nuclear Data's entire line of film recorders, accordingto the Elmsford, NY, company.
Visiplex intends to dominate the field of multiformat camerasas long as the technology is available and plans to increase itsmarket share through acquisition, according to Seamus Carroll,vice president of sales and marketing. Visiplex moved into PACSwith the acquisition of Genesys earlier this year (SCAN 8/10/94).
At the RSNA meeting, Visiplex displayed MRI Read Station, a three-monitorconfiguration of Imlogix displays developed for MRI studies. Visiplexalso displayed a new Windows-based version of the FilmFax productformerly marketed by Genesys.
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5